NASDAQ Panel Grants Ciphergen's Request for Listing on the NASDAQ Capital Market
August 25 2006 - 10:00AM
PR Newswire (US)
FREMONT, Calif., Aug. 25 /PRNewswire-FirstCall/ -- Ciphergen
Biosystems, Inc. (NASDAQ:CIPH) announced today that a Nasdaq
Listing Qualifications Panel has granted the company's request to
be listed on the Nasdaq Capital Market, effective with the market
open on Monday, August 28, 2006. By transferring from the Nasdaq
Global Market to the Nasdaq Capital Market, Ciphergen satisfies the
listing requirements for the NASDAQ. The Company's trading symbol
will remain CIPH. About Ciphergen Ciphergen Biosystems, Inc. is
focused on the discovery, development and commercialization of
high-value, molecular diagnostic products to improve patient care.
Ciphergen, along with its prestigious scientific collaborators, has
ongoing diagnostic programs primarily in oncology with an initial
focus in ovarian and prostate cancer. Based in Fremont, California,
more information about Ciphergen can be found on the Web at
http://www.ciphergen.com/ . Safe Harbor Statement Note Regarding
Forward-Looking Statements: This press release contains
forward-looking statements. For purposes of the Private Securities
Litigation Reform Act of 1995 (the "Act"), Ciphergen disclaims any
intent or obligation to update these forward-looking statements,
and claims the protection of the Safe Harbor for forward-looking
statements contained in the Act. Examples of such forward-looking
statements include statements regarding the pending listing of
Ciphergen common stock on the NASDAQ Capital Market. Actual results
may differ materially from those projected in such forward-looking
statements due to various factors, including the risk that
Ciphergen may not successfully complete the application and review
process. Investors should consult Ciphergen's filings with the
Securities and Exchange Commission, including its Form 10-Q filed
August 16, 2006, for further information regarding these and other
risks related to the Company's business. DATASOURCE: Ciphergen
Biosystems, Inc. CONTACT: Sue Carruthers, Investor Relations of
Ciphergen Biosystems, Inc., +1-510-505 2297 Web site:
http://www.ciphergen.com/
Copyright
Ciphergen Biosystems (NASDAQ:CIPH)
Historical Stock Chart
From May 2024 to Jun 2024
Ciphergen Biosystems (NASDAQ:CIPH)
Historical Stock Chart
From Jun 2023 to Jun 2024